Robert holds a bachelor’s degree in biochemistry and a master’s degree in biotechnology from the University of New Hampshire. He has worked in the industry for the past two years, advancing research in viral vector purification and oligo therapeutics for treating rare diseases. Since joining Nanolyx at the end of 2023, Robert has been helping to develop the company from the early stages, helping to build exposure and form strategic partnerships. Robert is highly motivated and skilled in networking, collaboration, and creative vision. Driven by a deep passion for sustainable innovation and disruptive market strategies, Robert brings charisma to Nanolyx’s mission that is compounded by a belief in this technology’s potential and solidarity with the underlying tenets that comprise our company culture.

Veer is an integral cofounder and former CEO of Nanolyx and is also an MD candidate at the Icahn School of Medicine at Mount Sinai. Veer worked alongside Dr. David Medina Cruz in advancing R&D in the Green Chemistry lab, spearheaded commercialization efforts, and navigated accelerators like NSF I-Corps and the National Cleantech Open. His skills shine through exemplary leadership, negotiations with legal entities, technology transfer, and advancing strategic partnerships with academia and industry. Veer is passionate about helping the world realize the innovative potential of green nanotechnology to address global health challenges.